Rosen Law Firm says PROCEPT BioRobotics investors face Sept. 22 lead plaintiff deadline
Rosen Law Firm says a class action has been filed over PROCEPT BioRobotics’ handpiece sales, inventory and 2025 guidance, and investors have until Sept. 22, 2026, to seek lead plaintiff status.
Rosen Law Firm says a class action has been filed against PROCEPT BioRobotics Corporation over alleged misleading statements about handpiece sales, inventory and 2025 guidance, and it is seeking a lead plaintiff by Sept. 22, 2026.
The notice, published Sept. 5, says the case covers investors who bought PROCEPT BioRobotics common stock, Nasdaq: PRCT, between Feb. 28, 2024, and Feb. 25, 2026, inclusive. Rosen says investors who fall within that window may be entitled to compensation through a contingency fee arrangement, with no out-of-pocket fees or costs.
The notice says the allegations center on PROCEPT’s sales practices and the company’s public statements about demand for its handpieces, which are used with its robotic system. Rosen says the lawsuit claims PROCEPT used an extensive discount program to spur bulk orders above procedure demand, pulling sales forward and inflating reported U.S. handpiece unit sales and revenues.
The notice also says the complaint alleges customer orders exceeded underlying procedure demand throughout the class period and that the gap widened over time. It says that, by the end of the period, the excess created more than 10,000 units of field inventory and left the company overstocked.
According to the notice, the suit further claims that statements about handpiece sales and field system utilization were overstated and that PROCEPT faced undisclosed operational and financial risk. Rosen says the case also alleges the company could not achieve its stated 2025 handpiece sales and revenue guidance and that the guidance lacked a reasonably achievable factual basis.
The notice says investors suffered damages when the true details entered the market. It identifies Rosen Law Firm, Phillip Kim, Esq., and Laurence Rosen, Esq., and provides contact information for investors who want to join the case.
Lead plaintiff status is available only by motion to the court, and Rosen says the deadline is Sept. 22, 2026. The notice says a class action has already been filed, but it does not provide the company’s response.
Sources
Editorial note: This article was prepared with AI assistance and includes source attribution for reader review.
View the Web StoryA visual, tap-through version of this reportThis is the AMP version of the article. Read the full article on Atlas Watchline.